Gulf International Bank (Uk) LTD Amgen Inc Transaction History

Gulf International Bank (Uk) LTD

$3.96 Billion
Q4 2024

A detailed history of Gulf International Bank (Uk) LTD transactions in Amgen Inc stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 41,281 shares of AMGN stock, worth $12 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

41,281

Previous 42,322 2.46%

Holding current value

$12 Million

Previous $13.6 Million 21.1%

% of portfolio

0.27%

Previous 0.35%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$258.78 - $328.31 $269,389 - $341,770	-1,041 Reduced 2.46%	41,281 $10.8 Million
Q3 2024 Oct 30, 2024	SELL	$309.38 - $337.38 $548,840 - $598,512	-1,774 Reduced 4.02%	42,322 $13.6 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $557,292 - $677,256	-2,121 Reduced 4.59%	44,096 $13.8 Million
Q1 2024 Apr 11, 2024	BUY	$268.87 - $324.56 $612,754 - $739,672	2,279 Added 5.19%	46,217 $13.1 Million
Q4 2023 Jan 11, 2024	SELL	$255.7 - $288.46 $1.25 Million - $1.42 Million	-4,908 Reduced 10.05%	43,938 $12.7 Million
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $1.12 Million - $1.39 Million	-5,136 Reduced 9.51%	48,846 $13.1 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $3.49 Million - $4.13 Million	-16,305 Reduced 23.2%	53,982 $12 Million
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $4.7 Million - $5.73 Million	-20,834 Reduced 22.86%	70,287 $17 Million
Q3 2022 Oct 07, 2022	SELL	$224.46 - $253.15 $1.32 Million - $1.49 Million	-5,878 Reduced 6.06%	91,121 $20.5 Million
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $156,190 - $173,812	-677 Reduced 0.69%	96,999 $23.6 Million
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $3.93 Million - $4.5 Million	-19,751 Reduced 16.82%	97,676 $22 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $67,289 - $78,837	-317 Reduced 0.27%	117,427 $25 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $106,512 - $118,167	-456 Reduced 0.39%	117,744 $28.7 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $2.93 Million - $3.42 Million	-13,222 Reduced 10.06%	118,200 $29.4 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $2.11 Million - $2.52 Million	-9,774 Reduced 6.92%	131,422 $30.2 Million
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $319,124 - $354,892	-1,360 Reduced 0.95%	141,196 $35.9 Million
Q2 2020 Jul 24, 2020	BUY	$197.81 - $242.74 $201,172 - $246,866	1,017 Added 0.72%	142,556 $33.6 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $97,680 - $129,551	-536 Reduced 0.38%	141,539 $28.7 Million
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $742,649 - $954,560	-3,925 Reduced 2.69%	142,075 $34.3 Million
Q3 2019 Oct 08, 2019	SELL	$174.11 - $208.62 $364,586 - $436,850	-2,094 Reduced 1.41%	146,000 $28.3 Million
Q2 2019 Jul 10, 2019	SELL	$166.7 - $195.41 $882,843 - $1.03 Million	-5,296 Reduced 3.45%	148,094 $27.3 Million
Q1 2019 Apr 18, 2019	SELL	$180.87 - $203.88 $78,859 - $88,891	-436 Reduced 0.28%	153,390 $29.1 Million
Q4 2018 Jan 08, 2019	SELL	$178.4 - $208.25 $12.6 Million - $14.7 Million	-70,765 Reduced 31.51%	153,826 $29.9 Million
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $1.28 Million - $1.44 Million	6,912 Added 3.18%	224,591 $46.6 Million
Q2 2018 Jul 05, 2018	BUY	$166.05 - $186.51 $805,508 - $904,760	4,851 Added 2.28%	217,679 $40.2 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $3.35 Million - $3.91 Million	-19,743 Reduced 8.49%	212,828 $36.3 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $38.9 Million - $44.4 Million	232,571	232,571 $43.4 Million

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Account

Gulf International Bank (Uk) LTD Amgen Inc Transaction History